These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 20646887)
1. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. Wang CL; Chea YW; Boll DT; Samei E; Neville AM; Dale BM; Merkle EM Eur J Radiol; 2011 Nov; 80(2):e1-7. PubMed ID: 20646887 [TBL] [Abstract][Full Text] [Related]
2. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable? Kinner S; Umutlu L; Blex S; Maderwald S; Antoch G; Ertle J; Gerken G; Lauenstein TC Eur J Radiol; 2012 Apr; 81(4):e625-8. PubMed ID: 22297185 [TBL] [Abstract][Full Text] [Related]
3. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Benndorf M; Schelhorn J; Dietzel M; Kaiser WA; Baltzer PA Eur J Radiol; 2012 Aug; 81(8):e849-53. PubMed ID: 22575171 [TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI: usefulness for differentiating intrapancreatic accessory spleen and small hypervascular neuroendocrine tumor of the pancreas. Kang BK; Kim JH; Byun JH; Lee SS; Kim HJ; Kim SY; Lee MG Acta Radiol; 2014 Dec; 55(10):1157-65. PubMed ID: 24259300 [TBL] [Abstract][Full Text] [Related]
5. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis. Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868 [TBL] [Abstract][Full Text] [Related]
6. The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma. Liu K; Peng W; Zhou Z Acta Radiol; 2013 May; 54(4):364-8. PubMed ID: 23386737 [TBL] [Abstract][Full Text] [Related]
7. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver]. Zhang HM; Ouyang H; Zhou CW Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014 [TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. Taouli B; Sandberg A; Stemmer A; Parikh T; Wong S; Xu J; Lee VS J Magn Reson Imaging; 2009 Sep; 30(3):561-8. PubMed ID: 19711402 [TBL] [Abstract][Full Text] [Related]
10. Perfusion-weighted MR imaging in the upper abdomen: preliminary clinical experience in 61 patients. Ichikawa T; Haradome H; Hachiya J; Nitatori T; Araki T AJR Am J Roentgenol; 1997 Oct; 169(4):1061-6. PubMed ID: 9308465 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T. Kakite S; Dyvorne H; Besa C; Cooper N; Facciuto M; Donnerhack C; Taouli B J Magn Reson Imaging; 2015 Jan; 41(1):149-56. PubMed ID: 24415565 [TBL] [Abstract][Full Text] [Related]
12. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors. Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828 [TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of small focal hepatic lesions (≤2.5 cm in diameter): a comparison of diffusion-weighted images before and after administration of gadoxetic acid disodium at 3.0T. Song KD; Kim YK; Lee WJ; Lee MW; Park MJ; Hwang J; Lee MH Acta Radiol; 2012 Jun; 53(5):485-93. PubMed ID: 22535883 [TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427 [TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted MR imaging of benign and malignant breast lesions before and after contrast enhancement. Janka R; Hammon M; Geppert C; Nothhelfer A; Uder M; Wenkel E Rofo; 2014 Feb; 186(2):130-5. PubMed ID: 23929263 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values. Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870 [TBL] [Abstract][Full Text] [Related]
19. Effect of Gd-EOB-DTPA on T2-weighted and diffusion-weighted images for the diagnosis of hepatocellular carcinoma. Saito K; Araki Y; Park J; Metoki R; Katsuyama H; Nishio R; Kakizaki D; Moriyasu F; Tokuuye K J Magn Reson Imaging; 2010 Jul; 32(1):229-34. PubMed ID: 20578029 [TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging in the characterization of focal liver lesions: efficacy of visual assessment. Battal B; Kocaoglu M; Akgun V; Karademir I; Deveci S; Guvenc I; Bulakbasi N J Comput Assist Tomogr; 2011; 35(3):326-31. PubMed ID: 21586924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]